Cytomegalovirus foscamet

Jabs DA, Enger C, Forman M, Dunn JP (1998b) Incidence of foscamet resistance and cido-fovir resistance in patients treated for cytomegalovirus retinitis. Antimicrob Agents Chemother... [Pg.173]

Sarasini A, Baldanti F, Furione M, Percivalle E, Brerra R, Barbi M et al (1995) Double resistance to ganciclovir and foscamet of 4 human cytomegalovirus strains recovered from AIDS patients, J Med Virol 47 237-244... [Pg.174]

Keywords Encephalitis Heipes simplex virus type 1 Varicella zoster virus Cytomegalovirus West Nile virus Acyclovir Valacyclovir Ganciclovir Cidofovir Famciclovir Foscamet Latencyneurological disorders Lifecycle... [Pg.327]

Foscamet is used for the treatment of cytomegalovirus (CMV) retinitis and mucocutaneous acyclovir-resistant herpes simplex virus (HSV) infections. It may also be beneficial in other types of CMV or HSV infections (Wagstaff and Bryson, 1994). [Pg.334]

Jacobson MA, Drew WL, Feinberg J, O Donnell JJ, Whitmore PV, Miner RD, Parenti D. Foscamet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis I99I I63(6) I348-5I. [Pg.1448]

Blanshard C, Benhamou Y, Dohin E, Lernestedt JO, Gazzard BG, Katlama C. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscamet and ganciclovir a randomized comparison. J Infect Dis 1995 I72(3) 622-8. [Pg.1448]

Lewis RA, Clogston P, Fainstein V, et al. Morbidity and toxic effects associated with ganciclovir or foscamet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med I995 I55(I) 65-74. [Pg.1448]

Katlama C, Dohin E, Caumes E, Cochereau-Massin I, Brancon C, Robinet M, Rogeaux O, Dahan R, Gentilini M. Foscamet induction therapy for cytomegalovirus retinitis in AIDS comparison of twice-daily and three-times-daily regimens. J Acquir Immune Defic Syndr 1992 5(Suppl l) S18-24. [Pg.1448]

Cytomegalovirus infection Maintenance and induction therapies Ganciclovir IV Foscamet Cidofovir... [Pg.442]

Lehoang P, Girard B, Robinet M, et al. Foscamet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1989 96 865. [Pg.346]

Foscamet is an antiviral agent that inhibits replication of all known herpes viruses, including cytomegalovirus (CMV), herpes simplex virus types 1 and 2 (HSV-1, HSV-2), human herpes virus 6 (HHV-6), Epstein-Barr virus (EBV) and varicella-zoster virus (VZV). It is indicated in the treatment of CMV retinitis in patients with AIDS treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients and as combination therapy with ganciclovir for patients who have relapsed after monotherapy with either drug. [Pg.286]

Foscamet (foscavir) Intravenous, Intravitreal Cytomegalovirus retinitis... [Pg.1101]

Diaz-Llopis, M., Chipont, E., Sanchez, S., Espana, E., Navea, A. and Menezo, J. L., Intravitreal foscamet for cytomegalovirus retinitis in a patient with acquired immimodeficiency s3mdrome. Am. J. Ophthalmol., 114, 742, 1992. [Pg.57]

A man with a kidney transplant taking corticosteroids and ciclosporin developed a cytomegalovirus infection that was treated with foscarnet 85 mg/kg daily. Despite efforts to minimise the nephrotoxic effects of the foscarnet (hydration with 2.5 litres of isotonic saline daily and nifedipine 80 mg the day before and during treatment) the patient developed non-ol-iguric worsening of his renal function after 8 days. Nine days after stopping the foscamet, the former renal function was restored. ... [Pg.1034]

Bacigalupo A, Boyd A, Slipper J, Curtis J, Clissold S. Foscamet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients. Expert Rev Anti Infect Ther 2012 10(ll) 1249-64. [Pg.432]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...